Conclusion
In our study, SARS-CoV-2 infected pregnant patients experienced more obvious inflammatory response, cellular immune deficiency and potential tissue necrosis. These may reflect the potential severity of the disease course in pregnancy, but the clinical outcomes are similar between the two groups. No evidence of neonatal infections and complications had been shown in this study. Timely, intensive, active management and surveillance activities from multidisciplinary medical cooperation may be beneficial for improving the outcomes of pregnant women confirmed to have SARS-CoV-2 infection and the neonates.